Vesugen

Most people who look up Vesugen want circulation and blood vessel support. It belongs to the Khavinson bioregulators, the short peptides developed at a gerontology institute in St. Petersburg, Russia, where each one is matched to an organ. Vesugen is the one assigned to blood vessels, and that's how the Russian capsule is labeled and how vendors describe the research vial.

The women searching for it are usually in midlife and paying new attention to their hearts. Heart and blood vessel risk climbs after menopause, once estrogen stops doing some of the quiet maintenance it used to, and that's the window when a peptide pitched at vessel aging starts to sound interesting. People mention cold hands and feet, staying sharp, and simply aging well, and they usually run Vesugen as one course in a yearly rotation with Pinealon for the brain, Cartalax for cartilage and skin, and Ovagen for the liver. Our answer on peptides for heart health sets it beside Cardiogen and SS-31.

The research has a second thread people don't expect. A good share of the published work on Vesugen's sequence is about brain cells, not blood vessels, and that's why it turns up in conversations about memory alongside Pinealon. If your interest is memory more than circulation, read the Pinealon page too, because the two overlap more than their labels suggest.

People who take it treat it as maintenance rather than a fix. They run a short course, then leave it alone for months, the same rhythm the Russian capsule label describes. Nobody we could find takes it every day, year round.

The Khavinson group's idea is that very short peptides can get inside a cell and nudge which genes get switched on, a bit like a sticky note on a recipe telling the cook which steps to repeat. Three amino acids is about as small as a peptide gets, small enough that the group argues it can reach the cell nucleus, where genes live.

For blood vessels, the group reported that Vesugen's sequence shifted genes in the cells lining blood vessels toward a younger pattern in lab cultures, including genes involved in keeping vessels relaxed and in how sticky the vessel wall is to passing immune cells. In aging human stem cells grown in a dish, it was one of the short peptides that changed the activity of genes tied to cell aging.

The brain thread runs through cell work, where it encouraged stem cells to turn into nerve cells, and a mouse study, where mice bred to develop an Alzheimer's-like disease kept more of the tiny branches nerve cells use to connect to each other. The developers have also described giving it to older adults in Russia in small studies of their own, which haven't been repeated by anyone else.

That's the whole picture so far: cell and animal work, a few small human reports, nearly all of it from one research network. The ideas hang together, and none of it has been tested in the kind of large trial that would tell you what it does in a woman's arteries.

In the US, vendors sell Vesugen as a freeze-dried powder, mostly in 20 mg vials, which you mix with bacteriostatic water (sterile water with a preservative, so a vial can be drawn from more than once) and inject under the skin. In Russia it's sold as capsules, each holding 10 mg of the peptide.

The amounts in circulation run from 200 mcg a day for 10 days on one education page, to 1 to 2 mg a day or every other day for 10 to 20 days on a community protocol site. The capsule label gives one or two capsules, once or twice a day, for a month. None of those comes from a human dosing study. The Vesugen dosage page sets each pattern out with its source, the math for a 20 mg vial, and how long a mixed vial lasts.

Once water goes into a vial, it keeps for 28 days in the fridge. At the low end of the amounts above, the 20 mg vial vendors sell holds far more than one course, so it pays to plan the course before you order.

Nobody has published a proper human safety study of Vesugen, so there's no measured list of side effects. The animal work didn't report harm at the amounts used, and the capsule has been sold in Russia as a supplement for years without a public safety warning we could find. That's encouraging, and it isn't the same as a trial.

What people report with injected peptides in this family is mostly a little redness or itch where the needle went in, which usually fades within the hour. People rotate the spot they inject.

A few situations deserve extra care. There's no information on pregnancy or breastfeeding. If you have a heart or blood vessel condition, or take blood thinners or blood pressure medicine, that's where a peptide aimed at blood vessels with no human data is hardest to judge. And because a research vial isn't a regulated product, the main everyday risk is what's actually in it, which is why we check vendors for independent lab testing and published certificates of analysis.

The synthetic peptide comes in two forms. The Russian capsule is swallowed and sold as a supplement, and the US research vial is powder for injection. The amounts don't carry over between them, since swallowed peptides are partly broken down in the gut, so capsule amounts run much higher than injected ones.

You may also see Ventfort, an older capsule in the same family made from an extract of animal blood vessels rather than the synthetic sequence. It's marketed for the same purpose, but it's a different product, and its amounts aren't Vesugen's. "Vesugen acetate" on a vendor page is the same peptide, listed as the salt form most powders come in.

Vesugen isn't approved by the FDA for anything. In the US it's sold as a research compound, labeled for research use, and buying it for that purpose is legal. In Russia the capsule is sold as a dietary supplement, not a prescription medicine. It isn't on the World Anti-Doping Agency's named list, though that list bans unapproved substances in general, so tested athletes treat it as off limits.

We haven't written a head-to-head page for Vesugen yet. People most often weigh it against Pinealon, its sibling for the brain, since both turn up in research on nerve cells. Ovagen and Cartalax are the family members for the liver and for cartilage and skin, and Epithalon is the longevity peptide with the deepest research base of the group.

When you compare prices, compare the cost per milligram, not the price of the vial, and look for a vendor that publishes independent lab results for the batch you're buying. That matters more for a lightly studied peptide like this one, where there's less testing across the market to fall back on.

It's sold for research, and the big human trials haven't been run yet. You knew that, it's why you're reading this and not the label.